Explanation

Off-label prescribing — using an FDA-approved medication for a purpose, population, or dosage not specified in the approved labeling — is legal, common, and widely accepted in psychiatric practice. Many evidence-based psychiatric treatments are used off-label because the FDA approval process is separate from the clinical evidence base. The legal standard in a malpractice case is not whether the use was FDA-approved but whether the prescribing decision met the standard of care. If the off-label use is supported by clinical evidence (peer-reviewed literature, practice guidelines, expert consensus) and the patient was appropriately informed through the consent process, the PMHNP has met the standard of care. Documentation of the clinical rationale for off-label use and the informed consent discussion is essential.

Key Takeaway

Off-label prescribing is legal and common in psychiatry. The PMHNP's protection is documentation of clinical rationale and informed consent.